Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incannex Healthcare (IXHL) Share-based Compensation (2023 - 2025)

Incannex Healthcare's Share-based Compensation history spans 3 years, with the latest figure at $7.5 million for Q4 2025.

  • For Q4 2025, Share-based Compensation rose 1631.26% year-over-year to $7.5 million; the TTM value through Dec 2025 reached $6.6 million, up 4.24%, while the annual FY2025 figure was $2.6 million, 70.78% down from the prior year.
  • Share-based Compensation for Q4 2025 was $7.5 million at Incannex Healthcare, up from -$2.6 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $7.5 million in Q4 2025 and bottomed at -$2.6 million in Q3 2025.
  • The 3-year median for Share-based Compensation is $879000.0 (2024), against an average of $1.6 million.
  • The largest YoY upside for Share-based Compensation was 1631.26% in 2025 against a maximum downside of 672.11% in 2025.
  • A 3-year view of Share-based Compensation shows it stood at $3.4 million in 2023, then crashed by 87.19% to $435000.0 in 2024, then surged by 1631.26% to $7.5 million in 2025.
  • Per Business Quant, the three most recent readings for IXHL's Share-based Compensation are $7.5 million (Q4 2025), -$2.6 million (Q3 2025), and $1.3 million (Q2 2025).